Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.
Saved in:
| Title: | Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine. |
|---|---|
| Authors: | Kofoed SV; Evaxion Biotech, Hørsholm, Denmark. svk@evaxion.ai., Barrio-Calvo M; Evaxion Biotech, Hørsholm, Denmark., Pavlidis MA; Evaxion Biotech, Hørsholm, Denmark., Kleine-Kohlbrecher D; Evaxion Biotech, Hørsholm, Denmark., Lausen M; Evaxion Biotech, Hørsholm, Denmark., Lunabjerg-Vestergaard C; Evaxion Biotech, Hørsholm, Denmark., Viborg N; Evaxion Biotech, Hørsholm, Denmark., Garde C; Evaxion Biotech, Hørsholm, Denmark., Rønø B; Evaxion Biotech, Hørsholm, Denmark., Friis S; Evaxion Biotech, Hørsholm, Denmark. sf@evaxion.ai. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Jul 24; Vol. 74 (9), pp. 276. Date of Electronic Publication: 2025 Jul 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-025-04120-1 |
